1-7 of 7
Weidong Han
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Changes in Glycosylation on the Cell Surface Result in Highly Potent and Long-Lasting Allogeneic CAR-T Therapy in Patients

Zeguang Wu, Jinhong Shi, Qiezhong Lamao, Jinxin Yang, Yuanyuan Qiu, Yang Liu, Feifei Liang, Changya Chen, Qingming Yang, Chunmeng Wang, Haixia Zhang, Zhonghan Yang, Yunyi Zhang, Yuting Yi, Xufen Zheng, Yun Sun, Kuiying Ma, Lingling Yu, Huihui Yang, Yongjian Zhang, Zhiqiang Wu, Yao Wang, Zhenguang Wang, Catherine CL Wong, Pengfei Yuan, Weidong Han, Wensheng Wei
Journal: Blood
Blood (2024) 144 (Supplement 1): 3405.
https://doi.org/10.1182/blood-2024-204568
Published: 2024
Journal Articles

Epigenetic agents plus anti-PD-1 reprogram the tumor microenvironment and restore antitumor efficacy in Hodgkin lymphoma

Clinical Trials & Observations
Jing Nie, Chunmeng Wang, Liangtao Zheng, Yang Liu, Chengcheng Wang, Yixin Chang, Yudi Hu, Bing Guo, Yuting Pan, Qingming Yang, Xueda Hu, Weidong Han
Journal: Blood
Blood (2024) 144 (18): 1936–1950.
https://doi.org/10.1182/blood.2024024487
Published: 2024
Includes: Supplemental data
Journal Articles

Safety and Efficacy of Parsaclisib in Combination with Rituximab in Patients with Previously Untreated Indolent B-Cell Lymphoma: Primary Analysis from a Phase 2 Study (REPLY)

Jinhong Shi, Yang Liu, Qingming Yang, Guanghua Rong, Nannan Lu, Zhipeng Guo, Zhifang Li, Bing Guo, Weidong Han
Journal: Blood
Blood (2023) 142 (Supplement 1): 6141.
https://doi.org/10.1182/blood-2023-181448
Published: 2023
Journal Articles

Targeting PRMT9 Elicits Cgas-Mediated Anti-Leukemia Immunity

Haojie Dong, Xin He, Lei Zhang, Wei Chen, Yichun Lin, Songbai Liu, Huafeng Wang, Wenfeng Huang, Sierra Min Li, Yinghui Zhu, Dandan Zhao, Lucy Ghoda, Rui Su, Jianjun Chen, Ritin Sharma, Patrick Pirrotte, Xiwei Wu, Weidong Hu, Weidong Han, Binghui Shen, Ya-Huei Kuo, Jie Jin, Amandeep Salhotra, Jeffrey Wang, Guido Marcucci, Yun Luo, Ling Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 4931–4933.
https://doi.org/10.1182/blood-2022-167366
Published: 2022
Journal Articles

Outcome of Tandem CD19/CD20 CAR Therapy with 3-Year Follow-up in R/R B-NHL

Yajing Zhang, Zhiqiang Wu, Yao Wang, Qingming Yang, Yang Liu, Chuan Tong, Weidong Han
Journal: Blood
Blood (2022) 140 (Supplement 1): 4606–4607.
https://doi.org/10.1182/blood-2022-166844
Published: 2022
Journal Articles

Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphoma

Clinical Trials & Observations
Chuan Tong, Yajing Zhang, Yang Liu, Xingyu Ji, Wenying Zhang, Yelei Guo, Xiao Han, Dongdong Ti, Hanren Dai, Chunmeng Wang, Qingming Yang, Wanli Liu, Yao Wang, Zhiqiang Wu, Weidong Han
Journal: Blood
Blood (2020) 136 (14): 1632–1644.
https://doi.org/10.1182/blood.2020005278
Published: 2020
Includes: Supplemental data
Journal Articles

Efficacy and Safety of PD-1 Inhibitor Plus GVD Chemotherapy in Patients with Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (rrPMLBCL)

Qian Mei, PhD, Wenying Zhang, MD, Yang Liu, MD, Qingming Yang, MD, John E.J. Rasko, MBBS, PhD, Weidong Han, PhD MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4072.
https://doi.org/10.1182/blood-2019-121768
Published: 2019